Drug intelligence / Profile preview

AKC-3001

Development stage: Preclinical
Lead developer: Akrocell Biosciences
Administration: Topical

Overview

AKC-3001 is a medical device developed by Akrocell Biosciences for the adhesion of cartilage and bone tissue. It is built upon the company's proprietary Elapatite™ platform technology. The device is designed to provide a biocompatible and effective adhesive interface to support the repair and regeneration of musculoskeletal tissues, particularly in cases of cartilage and bone damage. Currently in the preclinical stage, AKC-3001 aims to address clinical needs in orthopedic surgery where secure tissue bonding is critical for successful healing.

Other names: Elapatite

Beyond the preview

Go deeper on AKC-3001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AKC-3001.

Explore the full profile